Richard A. Zager, Ali Johnson  Kidney International 

Slides:



Advertisements
Similar presentations
Volume 56, Issue 5, Pages (November 1999)
Advertisements

Richard A. Zager, Ali Johnson  Kidney International 
Radiographic contrast media–induced tubular injury: Evaluation of oxidant stress and plasma membrane integrity  Richard A. Zager, Ali C.M. Johnson, Sherry.
Volume 94, Issue 3, Pages (September 2018)
Volume 64, Issue 5, Pages (November 2003)
Volume 60, Issue 3, Pages (September 2001)
Volume 62, Issue 6, Pages (December 2002)
Volume 88, Issue 6, Pages (December 2015)
Volume 68, Issue 6, Pages (December 2005)
Radiographic contrast media–induced tubular injury: Evaluation of oxidant stress and plasma membrane integrity  Richard A. Zager, Ali C.M. Johnson, Sherry.
Volume 80, Issue 8, Pages (October 2011)
Y.-H.H. Lien, K.-C. Yong, C. Cho, S. Igarashi, L.-W. Lai 
Volume 63, Issue 2, Pages (February 2003)
Volume 72, Issue 4, Pages (August 2007)
The cell cycle and acute kidney injury
Parenteral iron nephrotoxicity: Potential mechanisms and consequences1
Volume 58, Issue 1, Pages (July 2000)
‘Endotoxin tolerance’: TNF-α hyper-reactivity and tubular cytoresistance in a renal cholesterol loading state  R.A. Zager, A.C.M. Johnson, S. Lund  Kidney.
Richard A. Zager, M.D., Kristin M. Burkhart, D.S. Conrad 
Volume 54, Issue 4, Pages (October 1998)
Volume 63, Issue 5, Pages (May 2003)
Genistein protects the kidney from cisplatin-induced injury
Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis  Hua Liu, Radhakrishna Baliga  Kidney International 
Differential effects of glutathione and cysteine on Fe2+, Fe3+, H2O2 and myoglobin- induced proximal tubular cell attack  Richard A. Zager, Kristin M.
Volume 63, Issue 2, Pages (February 2003)
Volume 70, Issue 3, Pages (August 2006)
Karl A. Nath, Anthony J. Croatt, Jill J. Haggard, Joseph P. Grande 
Volume 67, Issue 6, Pages (June 2005)
Volume 68, Issue 5, Pages (November 2005)
Gilbert R. Kinsey, Liping Huang, Amy L. Vergis, Li Li, Mark D. Okusa 
Volume 80, Issue 12, Pages (December 2011)
Richard A. Zager, Ali C.M. Johnson, Sherry Y. Hanson, M.D. 
Richard A. Zager, Ali C.M. Johnson, Sherry Y. Hanson 
Down-regulation of Na+ transporters and AQP2 is responsible for acyclovir-induced polyuria and hypophosphatemia  Lúcia Andrade, Nancy A. Rebouças, Antonio.
Ischemic and non-ischemic acute kidney injury cause hepatic damage
Volume 66, Issue 6, Pages (December 2004)
Volume 72, Issue 3, Pages (August 2007)
Progressive endothelin-1 gene activation initiates chronic/end-stage renal disease following experimental ischemic/reperfusion injury  Richard A. Zager,
Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway  William A. Wilmer, Cynthia L. Dixon, Courtney Hebert 
Phenotypic characteristics of diabetic kidney involvement
Triglyceride accumulation in injured renal tubular cells: Alterations in both synthetic and catabolic pathways  A.L.I.C.M. Johnson, Andreas Stahl, Richard.
Volume 57, Issue 3, Pages (March 2000)
Volume 73, Issue 12, Pages (June 2008)
Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin- induced acute kidney injury  K. Negishi, E. Noiri, R. Maeda, D.
Growth and development alter susceptibility to acute renal injury
Volume 73, Issue 11, Pages (June 2008)
Volume 72, Issue 5, Pages (September 2007)
Resistance to ischemic acute renal failure in the Brown Norway rat: A new model to study cytoprotection  David P. Basile, Deborah Donohoe, X.I.A. Cao,
Volume 56, Issue 3, Pages (September 1999)
Volume 63, Issue 5, Pages (May 2003)
Volume 56, Issue 1, Pages (July 1999)
The C5a receptor has a key role in immune complex glomerulonephritis in complement factor H–deficient mice  Jessy J. Alexander, Lee Chaves, Anthony Chang,
The pathological role of Bax in cisplatin nephrotoxicity
Volume 56, Issue 6, Pages (December 1999)
Martin A. Turman, Scott L. Rosenfeld  Kidney International 
Sepsis syndrome stimulates proximal tubule cholesterol synthesis and suppresses the SR-B1 cholesterol transporter  Richard A. Zager, Ali C.M. Johnson,
MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis  Sang-Kyung Jo, Won Yong Cho, Su Ah Sung, Hyoung.
Volume 18, Issue 3, Pages (March 2010)
Volume 58, Issue 4, Pages (October 2000)
Volume 69, Issue 3, Pages (February 2006)
A functional immature model of chronic partial ureteral obstruction1
Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure  D.W. Johnson, B. Pat, D.A. Vesey, Z.
Volume 80, Issue 2, Pages (July 2011)
Volume 56, Issue 5, Pages (November 1999)
T-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis  Masashi Haraguchi, Wayne A. Border, Yufeng Huang,
Volume 62, Issue 5, Pages (November 2002)
Richard A. Zager, Ali Johnson, Sherry Hanson, Vivian Dela Rosa 
Acute nephrotoxic and obstructive injury primes the kidney to endotoxin-driven cytokine/chemokine production  R.A. Zager, A.C.M. Johnson, S.Y. Hanson,
Volume 60, Issue 6, Pages (December 2001)
Karen M. Lochhead, Richard A. Zager  Kidney International 
Presentation transcript:

Renal cortical cholesterol accumulation is an integral component of the systemic stress response  Richard A. Zager, Ali Johnson  Kidney International  Volume 60, Issue 6, Pages 2299-2310 (December 2001) DOI: 10.1046/j.1523-1755.2001.00071.x Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 Glycerol-induced myohemoglobinuria increases renal cortical free cholesterol (FC) and cholesteryl ester (CE) content. Values are presented as nmoles cholesterol per μmol phospholipid phosphate (N = 6 per group). These values are representative of the total cortical cholesterol pools that were then fractionated into detergent-resistant membranes (DRM) versus non-DRM pools Figure 2. Kidney International 2001 60, 2299-2310DOI: (10.1046/j.1523-1755.2001.00071.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 2 (A) Fractionation of total renal cortical free and esterified cholesterol into DRM versus non-DRM pools. The values represent the % to which each fraction contributed to the total recovered cholesterol content (the sum of the absolute values in the DRM + the non-DRM pools) in post-glycerol treated, and normal (control) mice. As shown, there was a modest and statistically significant increase in both free cholesterol (FC) and cholesteryl ester (CE) contributions to the DRM pool in glycerol treated kidneys, compared to controls. (B) Glycerol induced substantial azotemia. Both the % FC and % CE within the DRM fractions for the glycerol treated animals directly correlated with the animals' BUN concentrations. The r values for these comparisons are: FC, 0.90; CE, 0.78. Kidney International 2001 60, 2299-2310DOI: (10.1046/j.1523-1755.2001.00071.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 3 Effects of oral statin therapy of glycerol (glyc) induced acute renal failure (ARF). (A) A striking statin-induced reduction in the extent of glycerol-induced azotemia, as reflected by BUN concentrations 18 hours post-glycerol injection is apparent. Control BUN values were obtained from normal mice. The reduction in renal injury was also reflected by a significant decrease in the extent of histologic damage (see text). (B) The reduction is azotemia was likely explained by a decrease in glycerol-induced myolysis/hemolysis, as denoted by a striking decrease in plasma lactate dehydrogenase (LDH) values. Kidney International 2001 60, 2299-2310DOI: (10.1046/j.1523-1755.2001.00071.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 4 Relationship between BUN and LDH values for each mouse post glycerol injection with (▪) or without (^) statin therapy. A striking correlation (r = 0.94) between these two parameters was observed for the statin treated mice. However, no such relationship was observed for the glycerol mice that did not receive statin therapy (r = 0.09). Thus, these results strongly suggest that statin-mediated protection was due to a decrease in myolysis/hemolysis. Kidney International 2001 60, 2299-2310DOI: (10.1046/j.1523-1755.2001.00071.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 5 Effect of oral statin therapy on renal cortical cholesterol accumulation in glycerol (glyc)-induced myohemoglobinuric ARF. As can be observed, both FC (A) and CE (B) levels were modestly reduced by statin therapy (presumably due to a decrease in renal injury, not renal HMGCR inhibition, per se; see Discussion). Control (or normal) renal cortical FC/CE concentrations are presented for comparison. Kidney International 2001 60, 2299-2310DOI: (10.1046/j.1523-1755.2001.00071.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 6 Heat shock (HS) effects on renal cortical FC and CE content. Both FC and CE levels were significantly increased in response to the heat shock protocols (N = 10 animals in control and heat shock groups). Kidney International 2001 60, 2299-2310DOI: (10.1046/j.1523-1755.2001.00071.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 7 Correlation between the strength of the heat shock response, as gauged by HSP-72 expression, and the extent of FC (A) and CE (B) accumulation. The extent of the heat shock response was gauged on the basis of the HSP-72 expression, as assessed semiquantitatively by Western blot (1+, constitutive expression in normal cortex; 2+, 3+, 4+, mild, moderate, and marked increments, respectively). As depicted, strong correlations between HSP-72 scores and FC/CE quantities were observed. Kidney International 2001 60, 2299-2310DOI: (10.1046/j.1523-1755.2001.00071.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 8 Free and esterified cholesterol values in the aftermath of E. coli sepsis in mice with minimal azotemia (BUN <35 mg/dL). Free cholesterol (FC), and in particular cholesteryl ester (CE), levels were substantially elevated in these 6 mice, despite the fact that only modest azotemia existed. Kidney International 2001 60, 2299-2310DOI: (10.1046/j.1523-1755.2001.00071.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 9 Free and esterified cholesterol values in the aftermath of E. coli sepsis in mice with severe azotemia. The BUN values for this group of 11 mice were 114 ± 3 mg/dL. As with the data in Figure 8, highly significant FC (A) and CE (B) increments were observed. Despite the greater azotemia in these mice vs. those used for the Figure 8 data, comparable FC/CE accumulation was observed. This suggests that the CE/FC changes were not a direct result of an azotemic state. As shown in (C), the sepsis-induced cholesterol increases were associated with relative FC and CE enrichment of the DRM fraction (consistent with the results obtained in the glycerol experiments). Kidney International 2001 60, 2299-2310DOI: (10.1046/j.1523-1755.2001.00071.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 10 Western blot analysis of HMGCR, HSP-72 in renal cortex, and HMGCR in HK-2 cells. Row 1: Variable degrees of up-regulation of HMGCR following in vivo heat shock (HS) are observed, compared to amounts seen in sham treated control (C) mouse kidneys (∼80 kD). Row 2: The first two samples (left to right) denote that statin therapy did not demonstrably increase HMGCR expression in renal cortex. In contrast, glycerol (glyc)-induced myohemoglobinuria caused a notable increase in renal cortical HMGCR levels, compared to control tissues. Row 3: HMGCR expression in cortical tissues samples obtained from control mice and from mice subjected to 18 hours of sepsis syndrome. No increase, or perhaps a slight decrease, in HMGCR in the sepsis samples is observed. Row 4: HSP-72 expression following in vivo heat shock. Variable degrees of HSP-72 increments were observed, compared to control tissues. Overall, HSP-72 semiquantitative scores strongly correlated with renal cortical FC/CE expression (see Figure 7). Row 5: HMGCR expression in HK-2 cells. Control (C) denoted no Fe challenge; 5 Fe is 5 μmol/L ferrous ammonium sulfate complexed with hydroxyquinoline (FeHQ) challenge, and 7.5 Fe is 7.5 μmol/L FeHQ challenge. A strong dose-dependent relationship between the amount of added Fe and the amount of HMGCR expression is apparent. Kidney International 2001 60, 2299-2310DOI: (10.1046/j.1523-1755.2001.00071.x) Copyright © 2001 International Society of Nephrology Terms and Conditions